DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages

Breast cancer (BC) is the second leading cause of cancer deaths among women. DEK is a known oncoprotein that is highly expressed in over 60% of breast cancers and is an independent marker of poor prognosis. However, the molecular mechanisms by which DEK promotes tumor progression are poorly understo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pease, Nicholas A., Shephard, Miranda S., Sertorio, Mathieu, Waltz, Susan E., Vinnedge, Lisa M. Privette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409092/
https://www.ncbi.nlm.nih.gov/pubmed/32708944
http://dx.doi.org/10.3390/cancers12071936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409092/
https://www.ncbi.nlm.nih.gov/pubmed/32708944
http://dx.doi.org/10.3390/cancers12071936

Ejemplares similares